KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Acquisitions (2016 - 2025)

Historic Acquisitions for Resmed (RMD) over the last 16 years, with Q3 2025 value amounting to $522000.0.

  • Resmed's Acquisitions fell 3894.74% to $522000.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $139.1 million, marking a year-over-year increase of 47240.44%. This contributed to the annual value of $140.1 million for FY2025, which is 396.71% up from last year.
  • Latest data reveals that Resmed reported Acquisitions of $522000.0 as of Q3 2025, which was down 3894.74% from $138.6 million recorded in Q2 2025.
  • Resmed's Acquisitions' 5-year high stood at $992.1 million during Q4 2022, with a 5-year trough of $522000.0 in Q3 2025.
  • In the last 5 years, Resmed's Acquisitions had a median value of $8.4 million in 2021 and averaged $91.8 million.
  • In the last 5 years, Resmed's Acquisitions skyrocketed by 266242.52% in 2022 and then tumbled by 9924.35% in 2023.
  • Resmed's Acquisitions (Quarter) stood at $35.9 million in 2021, then soared by 2662.43% to $992.1 million in 2022, then tumbled by 99.24% to $7.5 million in 2023, then plummeted by 91.07% to $670000.0 in 2024, then decreased by 22.09% to $522000.0 in 2025.
  • Its Acquisitions was $522000.0 in Q3 2025, compared to $138.6 million in Q2 2025 and $670000.0 in Q4 2024.